TTOO — T2 Biosystems Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.02m
- $9.86m
- $7.19m
T2 Biosystems Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: T2 Biosystems Gets Notice Of Delisting From Nasdaq
Brief: T2 Biosystems Affirms Plans To Add Candida Auris Detection To The FDA-Cleared T2candida Panel
U.S. RESEARCH ROUNDUP-Ncino, Newmont, Seagen
T2 Biosystems Inc reports results for the quarter ended in December - Earnings Summary
Brief: T2 Biosystems Announces Q4 And Full Year 2022 Financial Results
T2 Biosystems Inc expected to post a loss of $1.70 a share - Earnings Preview
T2 Biosystems Inc expected to post a loss of $1.70 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Bank of America, Silvergate Capital, Energy firms
U.S. STOCKS ON THE MOVE-Lithia Motors, Sera Prognostics, Citigroup
U.S. STOCKS ON THE MOVE-Paramount, Krispy Kreme, Emergent BioSolutions
Brief: T2 Biosystems Announces Pricing Of $12 Million Public Offering
T2 Biosystems sinks on highly dilutive stock-and-warrants offering
U.S. STOCKS ON THE MOVE-Packaged food makers, energy firms, Thomson Reuters
U.S. STOCKS ON THE MOVE-Ford Motor, Cleveland-Cliffs, Exelon Corp
U.S. STOCKS ON THE MOVE-Nvidia, Peabody Energy, Zoetis
T2 Biosystems tumbles on equity offering plans
T2 Biosystems Inc expected to post a loss of $1.70 a share - Earnings Preview
Brief: T2 Biosystems Advances To The Phase 2 In HHS And The Steven And Alexandra Cohen Foundation’S Lymex Diagnostics Prize